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Abstract  
Under physiological and pathological conditions, extracellular vesicles (EVs) are present in the 
extracellular compartment simultaneously with soluble mediators. We hypothesized that cytokine 
effects may be modulated by EVs, the recently recognized conveyors of intercellular messages. In 
order to test this hypothesis, human monocyte cells were incubated with CCRF acute lymphoblastic 
leukemia cell line-derived EVs with or without the addition of recombinant human TNF, and global 
gene expression changes were analysed. EVs alone regulated the expression of numerous genes related 
to inflammation and signaling. In combination, the effects of EVs and TNF were additive, antagonistic 
or independent. The differential effects of EVs and TNF or their simultaneous presence were also 
validated by Taqman assays, ELISA and testing different populations of purified EVs. In the case of 
the paramount chemokine IL-8, we were able to demonstrate a synergistic up-regulation by purified 
EVs and TNF. Our data suggest that neglecting the modulating role of EVs on the effects of soluble 
mediators may skew experimental results. On the other hand, considering the combined effects of 
cytokines and EVs may prove therapeutically useful by targeting both compartments at the same time.  
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INTRODUCTION 
 
Extracellular vesicles (EVs) are membrane-surrounded structures. Based on their size and origin, EVs 
are broadly categorised into the following groups: exosomes, microvesicles (MVs) (also referred to as 
microparticles, shedding vesicles and ectosomes) and apoptotic bodies [1]. Although there is 
considerable overlap in the size distribution of the three main groups of EVs, exosomes are roughly 
50-100 nm in size, and are generated by the exocytosis of multivesicular bodies. MVs (100-1000 nm) 
are produced by budding off the plasma membrane [1]. Apoptotic bodies are generally assumed to be 
larger, over 1000 nm in diameter, and are produced via membrane blebbing in the course of apoptosis, 
although EVs less than 1000 nm in diameter are also produced during apoptosis [1]. Several recent 
reviews summarise our current knowledge of EV physiology and analytical challenges of the field [1-
5].  
EVs have long been suspected to transfer messages between cells, and a number of different functions 
have been associated with EVs such as antigen presentation[6] and the transfer of mRNA and miRNA 
(„shuttle” RNA) [7]. EVs may communicate protective messages [8], promote inflammation [9], and 
their composition changes depending on the circumstances [10]. 
The stimulating effect of a T-cell-derived supernatant on the human monocyte cell line U937 was 
observed as early as 1983 [11]. A later study demonstrated that T-cell derived- EVs were able to 
activate human monocytes in a way similar to direct cell-to-cell contact [12].  
However, most studies on EVs tend to focus on a single vesicle type, most frequently exosomes, and 
effects of different EV populations are rarely studied in combination. Furthermore, EVs and cytokines 
naturally occur in body fluids as a mixture, but no study to date has analysed the global gene 
expression effects of a combination of EVs and cytokines on cells.  
We hypothesized that EVs modulate the cellular effects of cytokines. Here we show that the effects of 
EVs, TNF or their combination on gene expression of recipient cells are substantially different.  
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MATERIALS AND METHODS 
 
Cell lines 
CCRF-CEM human T-cell lymphoma line and U937 human monocyte cell line were obtained from 
ATCC. The cell lines were cultured in RPMI medium (Sigma, Budapest, Hungary) containing 10% 
(v/v) fetal bovine serum (PAA, Budapest, Hungary), 2 mM glutamine, 100 U/mL each penicillin and 
streptomycin and occasionally 0.5% ciprofloxacin (Fresenius Kabi, Budapest, Hungary), at 37 °C in 
5% CO2/air. The cell lines were regularly tested for mycoplasma contamination using a DAPI-based 
mycoplasma detection. 
 
Experimental setup 
All experiments were performed in quadruplicates, unless otherwise stated. CCRF cells were grown to 
confluency. For the experiment, cells were resuspended at 0.5x10
6
 cells/ml density in serum-free 
RPMI medium containing 0.5% ciprofloxacin, and EV production was allowed to take place for 24 
hours. To avoid aggregation of EVs, co-sedimentation of protein aggregates with EVs and the potential 
damage of the membrane of EVs during high speed centrifugation, we chose a method for studying 
EVs that we expected to cause the least artefactual effects on EVs. Thus, the supernatant of cells was 
collected and treated as follows, in order to produce two different fractions: i) EV-containing, cell-free 
supernatant was prepared by centrifuging the supernatant for 10 min at 300 g and discarding the pellet; 
ii) EV-free, cell-free supernatant (control) was prepared by spinning the supernatant at 300 g for 10 
min, followed by 20,500 g 20 min and 100,000 g 60 min, harvesting the supernatant and filtering it 
through a 0.2 µm filter (Millipore, Budapest, Hungary) by hydrostatic pressure. 
The two different types of supernatants (total EV-containing and control) were divided in two aliquots 
each. Next, we added the EV-depleted or EV-containing supernatants (derived from 1 x 10
6
 CCRF 
cells) to each of the wells of 6-well tissue culture plates. Parallel wells containing EV-depleted or EV-
containing supernatants were supplemented with 10ng/mL TNFα. (Sigma, Budapest, Hungary) U937 
cells (5x10
6
 cells per well in 5 ml total volume) were added to each well of the plates. The cells were 
incubated for 24 hours at 37 
o
C in 5% CO2/air, harvested by spinning at 300 g for 5 min and washed 
once in PBS before RNA extraction. The supernatant was harvested and stored at -80 
o
C until an 
ELISA analysis of IL-8 concentration was performed. 
 
Determination of EV concentration and size distribution using qNano 
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Conditioned tissue culture supernatant of CCRF cells was centrifuged 300g 10 minutes, the pellet was 
discarded, and the supernatant was submitted to resistive pulse sensing analysis using a qNano 
instrument (IZON Science Ltd, New Zeland) as described before [13].  
 
Electron microscopy 
In order to characterize the vesicular composition of EV-containing supernatants, and to confirm that 
EV-free supernatants of CCRF cells did not contain any vesicular structures, we pelleted the 
conditioned media at 100,000 g for 60 min. The supernatants were then carefully removed and the 
pellets were fixed with 4% paraformaldehyde in 0.01 M PBS at room temperature for 60 minutes. 
Following washing with PBS, the preparations were postfixed in 1% OsO4 (Taab) for 30 minutes. 
After rinsing with distilled water, the pellets were dehydrated in graded ethanol, including block 
staining with 1% uranyl-acetate in 50% ethanol for 30 minutes, and were embedded in Taab 812 
(Taab). After overnight polymerization at 60°C, the pellets were sectioned and the ultrathin sections 
were analyzed using a Hitachi 7100 electron microscope equipped with a Megaview II (lower 
resolution, Soft Imaging System) digital camera. 
 
Total RNA isolation  
Total RNA was isolated from U937 cells using a PureLink RNA Mini Kit (Ambion Life Sciences, 
Budapest, Hungary) according to the manufacturer’s instructions. The purity and integrity of the RNA 
was analysed using Bioanalyzer RNA chips (Agilent, Kromat, Budapest, Hungary), and the RNA 
concentration was measured using a NanoDrop spectrophotometer. 
 
Microarray analysis 
Labelled cRNA was prepared according to the Agilent Low Imput QuickAmp Kit protocol and the 
4x44k Whole Human Genom oligo microarray (Agilent, Kromat, Budapest, Hungary) was performed 
according to the protocol. Microarray data were analysed as outlined below.  
The data discussed in this publication have been deposited in NCBI's Gene Expression Omnibus [14] 
and are accessible through GEO Series accession number GSE47897 
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE47897). 
 
Gene expression data generated by the microarray experiment were first analysed by Agilent's 
GeneSpring GX software. Three replicates of the following 4 types of samples were studied by the 
microarray: control, EV, EV+TNF, TNF, corresponding to treatments of U937 cells. Probes with less 
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than two-fold mean change in expression value compared to the control, and probes with compromised 
flags, were excluded from further analysis. A one-way ANOVA test was performed on the remaining 
probes in order to detect significant alterations in gene expression, utilizing Tukey’s post-hoc test and a 
Benjamini-Hochberg correction for multiple hypotheses. Corrected p values of less than 0.05 were 
considered statistically significant, unless otherwise stated.  
 
Reverse transcription and Taqman assays 
Following extraction the RNA was reverse transcribed: each 40 µl reaction contained 2 µg RNA, 5 
mM MgCl2, 10 mM dNTP (Promega, Budapest, Hungary), random primers (Promega) and 2µls of 50 
U/µl MuLV reverse transcriptase (Roche, Budaőrs, Hungary). The reaction was preformed in a Perkin 
Elmer DNA Thermal Cycler 480 under the following conditions: 42°C 40 min, 99°C 5 min, 20°C 5 
min. 
Quantitative real-time PCR of selected genes including HGPRT (endogenous control), CD36, CNR2, 
IL8, CCL2 was performed using Taqman probes and the reactions were run in an Applied Biosystems 
7900HT Fast Real-Time PCR system using the thermal cycling conditions of 20 min at 95 
o
C, 
followed by 40 cycles of 95 
o
C 1 s denaturation step and 60 
o
C 20 sec annealing and extension step. 
 
Testing the effects of a combination of purified MVs and TNF on the IL-8 mRNA expression of 
U937 cells 
In order to validate the results of the somewhat unorthodox experimental setup used for the microarray 
experiment, we used purified CCRF-derived MVs (20 µg/ml) with or without TNF (10 ng/ml), 
resuspended in serum-free RPMI. MVs were purified using the following workflow: 300 g 10 min → 
2000 g 20min → filtration via an 800 nm filter by gravity → 12,500 g 10 min. As a negative control, 
serum-free RPMI was used, with or without TNF (10 ng/ml). U937 cells were incubated for 24 hours 
at 37 
o
C in 5% CO2/air, harvested by spinning at 300 g for 5 min and washed once in PBS before RNA 
extraction, and IL-8 Taqman assays were carried out as described above. 
 
Interleukin-8 ELISA 
In order to confirm the detected gene expression changes on the protein level, interleukin-8 
concentration was measured in the supernatant of treated U937 cells, a DuoSet ELISA development kit 
(R&D Biosystems, Biomedica, Budapest, Hungary) was used, according to the manufacturer’s 
instructions.  
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Statistical analysis 
Beyond the statistical analysis of the microarray results repeated measures ANOVA with Tukey’s post 
test was used to analyse the data of the ELISA and Taqman assays by GraphPad Prism v.4. 
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RESULTS 
 
Identification and characterization of EVs in CCRF supernatant 
In this study we used 24h conditioned medium of CCRF cells as a source of EVs. To confirm the 
presence of EVs and to characterize the EV composition, we first analyzed the 100,000 g pellets of 
cell-depleted CCRF supernatants by TEM. The pellet contained intact vesicles (Fig 1A) surrounded by 
continuous membrane mainly in the size range of MPs. Sporadically, some cup-shaped structures with 
morphological features of exosomes, at around 100 nm in diameters were also visible. Using ImageJ 
[15], the size distribution of vesicles in the EV pellet was calculated and was found to be 29-754 nm, 
with a mean diameter of 212 nm. 
Next, an aliquot of the CCRF supernatant containing EVs was analysed using an NP200 membrane of 
IZON qNano, which detects particles with roughly over 150 nm diameter. The cell-free, EV-free 
medium contained virtually no particles, whereas the concentration of particles in the cell-free, EV-
containing medium was 2x10
8
 particles/ml. The size range of particles was between 170-1250 nm, 
with a mean diameter of 380 nm (Fig 1B). The discrepancy in the average particle diameter detected 
using qNano and ImageJ was possibly due to the differences in the detectable size range using the two 
methods. 
 
Effects of EVs, human recombinant TNF or their combination on the gene expression of U937 
cells 
We next incubated U937 cells with EV-containing or EV-free CCRF human T-cell supernatant in the 
presence or absence of recombinant human TNF. The effects on gene expression were compared using 
an Agilent gene expression microarray.  
 
Single gene-based analysis by ANOVA, using GeneSpring 
After excluding compromised flags and filtering for at least 2-fold gene expression changes using 
ANOVA analysis, a statistically significant (p<0.05) difference in gene expression was found in the 
case of 202 probes, which could be mapped to 154 unique, annotated genes or loci (Fig. 2B). The 
mean expression values of these 154 genes were used in all downstream analysis apart from Gene Set 
Enrichment Analysis (GSEA) (where only compromised flags were excluded). The nature of gene 
expression changes of these 154 genes (i.e. up- or downregulation) following the different treatments 
were plotted on a Venn diagram (Fig. 2A). TNF treatment, EV treatment and combined treatment 
induced statistically significant changes in the case of 80, 82 and 84 genes, respectively.  
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A relatively large group of genes (51 genes) were up- or downregulated following treatment with EVs 
only. In comparison, the paramount cytokine TNF up- or downregulated the expression levels of as 
few as 16 genes (exclusive TNF effect) that did not change upon EV or combined EVs+TNF 
treatment.  
A large number of genes (38) were upregulated following treatment with both TNF and TNF in 
combination with EVs. Among these were mainly inflammatory and anti-apoptotic molecules such as 
IL-8, ICAM-1, BCL3, and the chemokines CXCL10, CXCL11, CXCL3. Similarly, all treatments (EVs 
only, TNF only, combined EVs+TNF treatment) induced the upregulation of a number of 
inflammatory genes such as CCL2, CXCL2, RELB and FCAR.  
 
Cluster analysis of interaction patterns based on microarray results 
The pattern of interaction between cytokine and EV-related effects was further studied by K-means 
clustering, and we identified six clusters of significantly altered probes (ANOVA, p<0.05) (Fig. 3.). 
Clusters #1 and #6: Here, the effect could be accounted for by EVs, and the effect of TNF alone was 
negligible. These clusters contained genes strongly upregulated (cluster 6, e.g. CNR2) or 
downregulated (cluster 1, e.g. MT1B, CXCL14, TBXAS1, SOCS2, CMYC) by EVs. 
Cluster #2: In this cluster genes were downregulated by both TNF and combined EVs+TNF treatment, 
but unaffected by EVs only.  
Cluster #3 and 5: These clusters contained genes where combined EVs+TNF treatment resulted in an 
additive effect compared to single treatments (TNF or EV). Cluster #3 contained genes strongly 
upregulated by TNF, and the EVs contributed to this effect to a small extent (e.g. CXCL2, CXCL8, 
CXCL10 and MMP9). Cluster #5 contained genes that were upregulated by both EVs and TNF to a 
small degree, but the combined effect was more pronounced (e.g. CCL2, CXCL3, CD36, CD82 and 
CHI3L1).  
Cluster #4:  Here, effect of EVs on expression of these genes was negligible.  
 
GeneMania analysis and Gene set based analysis 
Next, in order to analyze interactions between genes, we used GeneMania plugin for Cytoscape to 
visualize co-expression, co-localization, genetic or physical interactions, as well as shared functions or 
domains. Following treatment with EVs only, the expression of IL8-like domain, Cytochrome P450 
enzymes, proteins with T-SNARE domain or Furin repeat were changed (Fig. S1). Genes, significantly 
differentially regulated after combined EVs+TNF treatment, included transmembrane-G-protein-
coupled receptors and chemokines with IL-8-like domain (Fig. 4A).  
  10 
For a less restricted analysis of biological significance of microarray results, gene set enrichment was 
studied on all non-compromised probes. After a screening for the number of enriched gene sets by the 
GSEA method, datasets based on Kyoto Encyclopedia of Genes and Genomes (KEGG) Pathways, 
Reactome, Chemical and Genetic Perturbations Database and Gene Ontologies were found to yield 
enriched gene sets. Regarding KEGG pathways, innate-like signaling pathways were most enriched in 
the presence of EVs. The top 60 genes of those sets only enriched after the combined EVs+TNF 
treatment, but not after TNF alone, were plotted against related, enriched GO terms (Fig. 4B). Many 
plasma membrane proteins, in particular cell surface receptors were differentially expressed after a 
combined EVs+TNF treatment. 
 
Experimental validation of the microarray results 
First, we carried out Taqman assays to confirm the microarray data on the expression changes of a 
select group of genes (Fig. 5A). Both TNF and the combined EVs+TNF treatment upregulated the 
expression of CCL-2. An additive effect of EVs and TNF was observed both in the case of IL-8 and 
CCL-2 mRNA levels. EV-containing supernatant caused a significant upregulation of CNR2 gene 
compared with EV-free supernatant and this enhancing effect was significantly diminished by the 
addition of TNF. TNF alone caused a tendency to decrease mRNA levels of this gene. Similar 
tendencies were observed in the case of CD36, although only the difference between TNF and the 
combined EVs+TNF treatment was significant. Therefore, we propose that EVS and TNF had an 
antagonistic effect on the gene expression levels of CD36 and CNR2.  
Next, we wanted to confirm changes of IL-8 expression at the protein level. Therefore, we measured 
interleukin-8 in the supernatant of U937 cells following treatment with EV-containing or EV-free 
supernatant ± TNF (n=6). The additive effect of the EV-containing supernatant and TNF on IL-8 
protein production was statistically significant (repeated measures ANOVA, Tukey’s post-test, p<0.01) 
(Fig. 5B).  
Finally we wanted to demonstrate that our observations could be reproduced using purified EVs also. 
To this end, we purified CCRF-derived MVs which we subsequently resuspended in RPMI medium. 
These MVs were used, with or without the addition of TNF (10 ng/ml), to treat U937 cells. Compared 
to the treatment with MVs or TNF only, the combined MPs+TNF treatment resulted in a statistically 
significant upregulation of IL-8 mRNA levels (Fig. 5C) that was substantially higher than those 
observed in the presence of either MVs or TNF alone.  
Further experimental validation work is described and shown in Fig S3.  
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DISCUSSION 
 
Over the past half a century, numerous studies investigated the effects of soluble mediators in different 
in vitro settings to gain an insight to the functions of cytokines/chemokines. Approximately 15 years 
ago, a novel field evolved, demonstrating the presence and physiological/pathological significance of 
purified EV preparations in vitro for cellular effects. Even though in vivo soluble mediators and 
extracellular vesicles are present simultaneously in the extracellular space, up until now, their 
combined presence has not been taken into consideration. Thus, the present study was carried out to fill 
this gap.   
In order to test cellular effects of EVs, it is widely accepted to use purified EVs. However, this 
approach requires caution because of the lack of quality control tests for EV integrity. A common 
problem with vesicle pellets is aggregation, which makes it difficult to ensure even EV load in 
different treatments. EVs, in particular MPs, may also get damaged in the course of serial 
ultracentrifugation (similar to necrosis of cells). A third common confounding factor is co-pelleting of 
protein aggregates with EVs [16]. Furthermore, using pellets results in testing concentrated vesicles. 
For these reasons, we treated recipient cells with cell-depleted supernatant of EV-donor cells. As a 
negative control, we used supernatant depleted both in cells and EVs. This way, we were able to 
dissect the effects of cytokines present in the supernatant from the effects of EVs. We proved the 
validity of this experimental design by reproducing the interaction of EVs and TNF using purified 
MPs. Intriguingly, treatment with a combination of purified MVs and TNF induced significantly 
higher IL-8 mRNA levels than treatment with MVs or TNF alone, producing a synergistic rather than 
additive effect. One possible explanation for this synergistic effect could have been binding of TNF on 
the surface of MPs, since TNF has been shown to associate with EVs [17]. However, we were able to 
experimentally rule out this possibility (Fig. S3B). Therefore, we speculated that convergent signaling 
pathways rather than TNF accumulation on the surface of MVs were responsible for the observed 
additive/synergistic effect. There might be several possible explanations for the synergism between the 
effect of TNF and EVs. In case of IL-8, one possible mechanism suggested by GSEA analysis involves 
the upregulation of nuclear factor NF-kappaB, which acts both upstream of IL-8 and downstream of 
TNF.  In another set of GSEA analyses (focusing on transcription factors that might induce the gene 
expression changes observed in the presence of EVs), sterol regulatory element-1 (SREBF1) appeared 
the most likely transcription factor responsible for the EV-induced effects. SREBF1 does not directly 
influence the gene expression of IL-8. However, according to GeneMania it physically interacts with 
CREB1, which is involved in the regulation of IL-8. This parallel signaling path could also potentially 
  12 
aid the upregulation of IL-8 in the presence of TNF. Yet another possibility for the modulating effect 
of EVs would be a mechanism involving their RNA cargo, mainly miRNAs. Although our 
bioinformatics approach, using miRwalk [18] did not result in any clue on a specific set of miRNAs 
that might be involved in the effect, this possibility can not be excluded.  
Our study is the first to compare the effects of EVs in the presence or absence of a cytokine, on the 
global gene expression profile of recipient cells in a hypothesis-free system. Here we show that the 
presence of T-cell derived EVs or TNF alone, or in combination, causes differential gene expression 
patterns of U937 monocyte cells. The expression of 51 genes was statistically significantly altered 
following treatment with EVs compared to control. Thus, EVs are sufficient to regulate the expression 
of a large number of genes.  
As demonstrated by a network of GO terms, a combined EVs+TNF treatment not only enhanced a 
cluster of inflammatory cytokines and members of the NF-κB pathway, but also caused a prominent 
effect on genes associated with cell surface receptor signaling, cytokine binding, membrane transport 
and genes associated with the plasma membrane (Fig. 4B, Fig. S2).   
Interestingly, we found that the expression of only 16 genes was significantly altered due to the effects 
of TNF alone, compared to the control group. Most of the genes modulated by TNF (80 in total) in this 
study were also affected by a combined treatment with TNF and EVs, and EV treatment alone. This 
may suggest that EVs fine-tune the effects of TNF, and cross-talk exists between cytokines and EVs. 
Importantly, several anti-inflammatory genes were significantly upregulated by treatment with EVs. 
Thus, EVs, besides promoting the induction of inflammation, may also potentially contribute to the 
resolution of inflammation. A similar pattern of regulation was observed by Wahlgren et al [19] who 
looked at the combined effects of IL-2 and autologous exosomes on the cytokine profile of T 
lymphocytes. Conspicuously, we found that the genes repressed by treatment with EVs in this study 
outnumbered the genes enhanced by EV treatment. Furthermore, the number of repressed genes was 
also large (29) compared with the number of genes downregulated in the other treatments in this study. 
Exosomes transfer mRNA and microRNA between cells (termed exosomal shuttle RNA) [7], and a 
similar role of MVs has also been shown [20]. The extensive regulatory function of microRNAs in the 
immune system via repressing target genes, is well-known [21], and so microRNAs in EVs are 
potentially responsible for repressing target genes in recipient cells.  
IL-8, a potent chemo-attractant for neutrophils, basophils and T cells, and an activator of neutrophils, 
appeared to be a central player in the effects of all treatments compared with control. Thus, we 
validated its expression at the mRNA and protein level also. The induction of IL-8 expression at the 
mRNA and protein levels in monocytes by EVs is in keeping with data by Baj-Krzyworzeka et al. 
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[22]. These authors observed that tumour-derived MVs not only serve as a storage pool of IL-8 mRNA 
and protein, but also induce the de novo production of IL-8 and several CC cytokines (CCL2-5) by 
monocytes [22]. IL-8 production by synoviocytes was also induced by platelet-derived MVs in a 
seminal study on the role of platelet-derived MVs in arthritis [9].  
GSEA results showed a strong association of the EV-regulated gene modules with those of a previous 
study on the effects of oxidised phospholipids on endothelial cells [23]. An interesting connection with 
the above study on oxidised phospholipids is our finding that treatment with EVs induced strong 
upregulation of CD36 (Fig. 5A). The scavenger receptor CD36 plays a variety of essential roles in the 
body. It recognises oxidised phospholipids [24], binds apoptotic cells via interacting with oxidised 
phosphatidylserine [25], and it also appears to be important in the uptake of vesicles. At least some of 
the binding of phosphatidylserine-containing vesicles to monocyte cells could be attributed to CD36 
[26]. Therefore, it is not surprising that treatment with EVs caused an upregulation of one of their 
putative receptors.  
The G-protein-coupled cannabinoid receptor 2 (CNR2, CB2) was strongly induced by treatment with 
EVs, and this effect was diminished by the additional presence of TNF. CNR2 is the “peripheral” 
cannabinoid receptor, mostly expressed by cells of the immune system and responsible for mediating 
the non-psychoactive effects of cannabinoids such as analgesia and immunosuppression [27]. Although 
relatively little is known about the cannabinoid receptors, CNR2 has evoked medical interest as an 
inducer of apoptosis, inhibitor of angiogenesis and skin tumour growth [28], and a potent anti-
inflammatory and immunosuppressive agent.[29]. CNR2 is also a target receptor of the dietary 
cannabinoid beta-caryophyllene, which, via the stimulation of CNR2, was able to achieve potent anti-
inflammatory effects in wild-type, but not in Cnr2-/- mice [30]. The potent upregulation of CNR2 by 
EVs may also reflect the anti-inflammatory effects of EVs.  
This study proved that the combined effects of EVs and cytokines differ from their independent effects 
and points out that EVs likely modify the effects of inflammatory cytokines. The data presented her 
give a new insight into inflammatory processes. We propose that testing the combined effects of 
soluble mediators and extracellular vesicles may model the in vivo effects of these mediators on cells 
more accurately than testing them separately. Our data may provide an explanation why targeting of 
certain soluble mediators does not always lead to the desired therapeutic effects. Furthermore, 
uncoupling the interaction of EVs and soluble mediators may open a novel avenue for a more effective 
therapeutic intervention.  
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Figure legends 
Figure 1. Determination of EV quality, composition and size distribution. 
A) Transmission electron micrograph of CCRF-derived EVs. Transmission electron micrograph of 
extracellular vesicles pelleted by 100,000 g for 60 min from cell-free supernatants of CCRF cells. A 
Hitachi 7100 electron microscope equipped with a Megaview II (lower resolution, Soft Imaging 
System) digital camera were used to acquire the images.  
B) IZON qNano analysis of the size distribution and concentration of extracellular vesicles. Cell-
depleted CCRF supernatants, containing EVs, were analysed using an NP200 membrane of IZON 
qNano, at a strech value of 47 mm, 120 nA current and 10 cm water pressure. At least 500 particles 
were detected. Calibration was performed using known concentration of beads CPC200C (from IZON) 
diluted 1:1000 in RPMI. The concentration of particles was 2x10^8 particles/ml. The size range was 
between 170-1250 nm, with a mean diameter of 380 nm, and a mode diameter of 270 nm. 
 
Figure 2. Significant gene expression changes based ANOVA analysis of the microarray data, 
using GeneSpring.  
A) Venn diagram demonstrating the number of significantly up- or downregulated genes (ANOVA, 
p<0.05) after each treatment. Upregulation is indicated by red, downregulation by blue arrows. 
B) A list of genes showing the names of significantly up- or downregulated genes (ANOVA, p<0.05) 
after each treatment. Among the genes significantly regulated by EVs there were some genes 
associated with vesicular trafficking. The multivalent protease inhibitor WFIKKN1 was one of the 
genes significantly upregulated by EVs. The protein product of this gene has been proposed to act as 
an inhibitor of serine proteases and metalloproteases [31]. A few genes involved in promoting 
inflammation, such as CXCL14, a potent neutrophil chemoattractant, as well as TBXAS1 were 
downregulated by treatment with EVs. 
 
Figure 3. Heatmap of gene expression changes and clusters of gene interaction patterns. 
In order to generate a heatmap of gene expression changes, we used hierarchical clustering on gene 
entities with Pearson’s Centered similarity measure and centroid linkage rule. Individual clusters of 
genes showing similar changes in expression pattern upon treatment were generated using K-means 
clustering. Here, genes differentially expressed after any one of the treatments (ANOVA, p<0.05), are 
hierarchically clustered based on the pattern of effects. Upregulation is indicated by red, 
downregulation by blue colour, whereas yellow represents no change compared to control.  
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Figure 4. Network analysis of genes modulated by a combined EVs+TNF treatment 
A) Interaction network of genes modulated by EV+TNF treatment compared with TNF 
treatment alone.  Based on the results of the microarray, GeneMania plugin [32-34] for Cytoscape 
was used to find and visualize functional clusters of significantly altered genes. Gene sets showing 
significant alteration in any one of the three treatments compared to control (pairwise ANOVA) were 
queried for co-expression, protein-protein interactions, shared domains and co-localization. The 
program was set to find at maximum 20 relevant attributes. This interaction network shows genes 
significantly differentially expressed after a combined EVs+TNF treatment compared to treatment with 
TNF alone. Upregulation is indicated by red, downregulation by blue colour, the left side of the nodes 
is coloured according to gene expression after TNF treatment, the right side according to gene 
expression after the combined EVs+TNF treatment.  
B. Network of GO terms, only enriched after a combined, EVs+TNF treatment, but not TNF 
treatment alone. Beyond single-gene analysis, Gene Set Enrichment Analysis (GSEA) was also 
applied, using the standard implementation of the method by Subramanian, Tamayo, et al [35-37], 
currently called GSEA v3.1, available from the Broad Institute via the web 
(http://www.broadinstitute.org/gsea/index.jsp). Given the limited number of conditions, we did all 
analyses with 1000 permutations based on the genotype. Gene sets were obtained from the c2, c3, c4 
and c5 branches of the Molecular Signatures Database (MSigDB v3.1) [38], excluding gene sets that 
contain less than 15 or more than 500 entities. As a screening test, we investigated all datasets in the 
corresponding branches of MSigDB and counted the number of gene sets showing a significant 
enrichment at a false detection rate (FDR) < 25% at nominal p value < 5%. GSEA results of Gene 
Ontology (GO) terms (c5) were visualized using Cytoscape and its Enrichment Map [39]. For network 
generation in Enrichment Map, we used the standard settings (p-value cut-off 0.005; FDR cut-off 0.1; 
Overlap coefficient 0.5; Combined constant 0.5). Here, the top 60 genes of those sets only enriched 
after the combined EVs+TNF treatment, but not after TNF treatment alone, were plotted against 
related, enriched GO terms. In the figure, genes are connected to the relevant terms. Colour and node 
size represent expression after a combined EVs+TNF treatment. Upregulation is indicated by red, 
downregulation by blue colour.  
 
Figure 5. Validation of the microarray results using Taqman assays, an IL-8 ELISA assay and 
using purified MVs and TNF. 
Changes in mRNA and protein levels of selected genes upon different treatments were detected by 
Taqman real-time PCR and ELISA assays. A) The mRNA level expression of CNR2, CD36, IL-8 and 
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CCL2 in the four treatments were detected by Taqman real-time PCR assays (Mean  SEM, n=4). For 
these assays, the original RNA samples also utilised for the microarray analyis, were used. B) Protein 
concentration of IL-8 in the supernatant of U937 cells following the four treatments, as detected by a 
commercially available ELISA assay (Mean  SEM, n=4). Data were analysed by repeated measures 
ANOVA with Tukey’s post test. Differences with p 0.05 were considered statistically significant. One 
asterisk indicates a statistically significant difference at the p 0.05 level, two asterisks indicate a 
statistically significant difference at the p 0.01 level and three asterisks indicate a statistically 
significant difference at the p 0.001 level. C) In order to prove the existence of a cross-talk between 
EVs and cytokines, we used purified MV populations, resuspended in RPMI, to treat U937 cells. The 
gene expression levels of IL-8 were monitored in the treated cells, using Taqman gene expression 
assays (Mean  SEM, n=3). Data were analysed by repeated measures ANOVA with Tukey’s post test. 
Differences with p 0.05 were considered statistically significant. Three asterisks indicate a statistically 
significant difference at the p 0.001 level. 
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